Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News DiagnaMed Holdings Corp DGNMF


Primary Symbol: C.DMED

Technology Software - Application
DiagnaMed Holdings Corp. is a Canada-based healthcare technology company focused on brain health using artificial intelligence (AI). The Company is commercializing BRAIN AGE Brain Health AI Platform, a consumer brain health and wellness AI solution that estimates brain age and provides a brain health score. The BRAIN AGE Brain Health AI Platform (BRAIN AGE) leverages its electroencephalograph... see more

Recent & Breaking News (CSE:DMED)

DiagnaMed and EIREX Collaborate to Develop and Commercialize Novel Modular Technology Producing Hydrogen from Water

GlobeNewswire November 14, 2024

DiagnaMed Announces Stock Option Grants and Shares for Debt Settlement

GlobeNewswire November 13, 2024

DiagnaMed Files U.S. Patent Application for Novel Methods of Producing Molecular Hydrogen

GlobeNewswire November 7, 2024

DiagnaMed Advancing the Medical Potential of Hydrogen

GlobeNewswire October 30, 2024

DiagnaMed Expands with Drug and Clinical Research AI Platform

GlobeNewswire August 21, 2024

DiagnaMed Offering its Brain Health AI Platform for Investigating Weight Loss Drugs, such as Semaglutide (GLP-1), on Brain Function

GlobeNewswire August 15, 2024

DiagnaMed Cancels Previously Announced Private Placement

GlobeNewswire July 3, 2024

DiagnaMed Announces LIFE Offering of up to $650,000

GlobeNewswire May 15, 2024

DiagnaMed's BRAIN AGE® Brain Health AI Platform Targeting Multi-Billion Digital Brain Health Market

GlobeNewswire May 15, 2024

DiagnaMed's BRAIN AGE® Brain Health AI Platform Accomplishes Clinical Validation Milestone with Peer-Reviewed Paper

GlobeNewswire April 25, 2024

DiagnaMed Announces Canadian Launch of BRAIN AGE® Brain Health AI

GlobeNewswire April 23, 2024

DiagnaMed Adds New Launch Site of CERVAI(TM) Brain Health AI

GlobeNewswire April 3, 2024

DiagnaMed Announces BRAIN AGE® Trademark Registration Approved by CIPO

GlobeNewswire March 20, 2024

DiagnaMed Strengthening Intellectual Property Support for CERVAI(TM) Brain Health AI Solution

GlobeNewswire March 14, 2024

DiagnaMed Accelerates Commercialization Initiatives of CERVAI(TM) Brain Health AI Solution

GlobeNewswire March 11, 2024

DiagnaMed Announces Test Launch of CERVAI(TM) Brain Health in University Brain Health Center

GlobeNewswire February 28, 2024

DiagnaMed Announces Pilot Launch of CERVAI(TM) Brain Health AI Solution

GlobeNewswire January 17, 2024

DiagnaMed Accelerates Commercialization of CERVAI(TM) Brain Health AI Platform with Acceptance into the SOPHIE Program

GlobeNewswire November 15, 2023

DiagnaMed Launches New Healthcare Provider Network Program for CERVAI(TM) Brain Health AI Platform in Canada and the USA

GlobeNewswire October 3, 2023

DiagnaMed Provides Update for its Brain Health AI Platform, CERVAI(TM)

GlobeNewswire September 13, 2023